Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Myelodysplastic syndromes].

C Garandeau1, E Pautas, M Andreux

  • 1Laboratoire d'hématologie, Groupe hospitalier Charles-Foix-Jean Rostand, 7, avenue de la République, 94205 Ivry-sur-Seine Cedex.

Annales De Biologie Clinique
|August 10, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Specificities of Meningitis and Meningo-Encephalitis After Kidney Transplantation: A French Retrospective Cohort Study.

Transplant international : official journal of the European Society for Organ Transplantation·2023
Same author

Type I interferon response and vascular alteration in chilblain-like lesions during the COVID-19 outbreak.

The British journal of dermatology·2021
Same author

Imbalance between procoagulant factors and natural coagulation inhibitors contributes to hypercoagulability in the critically ill COVID-19 patient: clinical implications.

European review for medical and pharmacological sciences·2020
Same author

Anticoagulation decisions in elderly patients with stroke.

Revue neurologique·2020
Same author

New rules of ABO-compatibility in kidney transplantation.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2019
Same author

Pulsed cavitational therapy using high-frequency ultrasound for the treatment of deep vein thrombosis in an in vitro model of human blood clot.

Physics in medicine and biology·2017
Same journal

A morphology-driven proof-of-concept study linking interphase nuclear abnormalities to dicentric-mediated genomic instability.

Annales de biologie clinique·2026
Same journal

Analytical validation and clinical concordance of Diazyme free light chain assays on the Cobas® platform compared with Freelite™.

Annales de biologie clinique·2026
Same journal

Small-cell secondary plasma cell leukemia mimicking low-grade B-cell lymphoma.

Annales de biologie clinique·2026
Same journal

[Multiple myeloma and analytical discrepancy in serum free light chain assay: a case report].

Annales de biologie clinique·2026
Same journal

[Summary of the 34th National Conference of the National College of Hospital Biochemistry].

Annales de biologie clinique·2026
Same journal

Assessment of the carbon footprint of an automated biochemistry toxicology platform: feedback from Rouen University Hospital.

Annales de biologie clinique·2026
See all related articles

Myelodysplastic syndromes (MDS) are stem cell disorders primarily affecting older adults. Diagnosis involves examining blood and bone marrow, differentiating MDS from other conditions, and classifying subtypes for prognosis and treatment.

Area of Science:

  • Hematology
  • Oncology
  • Stem Cell Biology

Context:

  • Myelodysplastic syndromes (MDS) are clonal stem cell disorders prevalent in individuals over 60.
  • Diagnosis relies on blood and bone marrow examination, excluding conditions like vitamin deficiencies or cytotoxic therapy effects.
  • The FAB classification categorizes MDS into five subtypes based on blast percentages, sideroblasts, and monocyte counts.

Purpose:

  • To provide a comprehensive overview of Myelodysplastic Syndromes (MDS).
  • To detail diagnostic criteria, including blood and bone marrow analysis.
  • To outline the FAB classification system and its parameters for MDS subtyping.

Summary:

  • MDS are clonal hematopoietic stem cell disorders predominantly affecting the elderly.

Related Experiment Videos

  • Diagnostic evaluation includes blood/marrow morphology, ruling out deficiencies or therapy-induced dysplasia.
  • The FAB classification defines subtypes (e.g., refractory anemia, CMML) based on specific cellular parameters.
  • Key diagnostic findings include normo/macrocytic anemia, neutropenia, thrombocytopenia, and specific red blood cell/neutrophil/platelet abnormalities.
  • Prognosis and treatment decisions are influenced by FAB subtype, patient age, blast percentage, cytopenias, cytogenetics, and HLA-identical donor availability.

    • Impact:

    • Establishes diagnostic standards for Myelodysplastic Syndromes.
    • Facilitates accurate subtyping for tailored treatment strategies.
    • Informs prognostic assessments based on clinical and laboratory findings.